Wall Street Breakfast Merck talks send Cidara soaring
8 snips
Nov 14, 2025 Merck is on the brink of acquiring Cidara Therapeutics for over $3.3 billion, a move that could shake up the pharmaceutical landscape. Meanwhile, the U.S. is opening trade pathways with several Latin American countries, enhancing market access. In alarming news, DoorDash has reported a cybersecurity breach affecting user data. The podcast also touches on comments from the Fed regarding interest rates, Google's proposed changes in adtech following a fine, and Blue Origin’s successful Mars mission launch.
AI Snips
Chapters
Transcript
Episode notes
Merck Nears Big Biotech Deal
- Merck is reportedly nearing a deal to acquire Sedera Therapeutics for above its $3.3 billion market cap.
- The deal may include cash up front plus milestone-based future payouts tied to clinical trials.
U.S. Expands Latin America Market Access
- The U.S. will lift tariffs and expand market access with Argentina, Ecuador, Guatemala, and El Salvador under a new framework.
- Argentina and Ecuador will open preferential or reduced access for medicines, machinery, wine, nuts, and other agricultural goods.
Strengthen Security After Breaches
- DoorDash says it identified and shut down an unauthorized cybersecurity incident affecting user information.
- The company is boosting security, adding employee training, hiring outside investigators, and involving law enforcement.